Raxclav 625 mg Tablet
strip of 6.0 tablets.Prescription required
About this product:
| Salt Composition: | Cefuroxime (500mg) + Clavulanic Acid (125mg) |
| Manufacturer: | Signova Pharma Pvt Ltd |
| Storage: | Below 25 degree celcius |
Out of Stock
Have doubts about this medicine?
Have doubts about this medicine?
Raxclav 625 mg Tablet is a combination medicine used to treat various types of bacterial infections by preventing the growth and spread of microorganisms. Raxclav 625 mg Tablet is a prescription medicine used to treat bacterial infections. It can be taken with or without food but should be taken at a fixed time for better efficacy. Do not exceed the recommended dose, and complete the full course of treatment even if you feel better. Common side effects include nausea, vomiting, diarrhea, and indigestion. Seek immediate medical help if you experience any allergic reactions. Consult your doctor if you are pregnant, breastfeeding, or taking other medications. Avoid alcohol as it may cause drowsiness. Ensure adequate rest, a healthy diet, and plenty of water for faster recovery. Your doctor may recommend laboratory tests to monitor the medicine's effects.
Raxclav 625 mg Tablet is a combination of Cefuroxime and Clavulanic Acid. Cefuroxime prevents the formation of the bacterial protective covering, essential for bacterial survival. Clavulanic Acid inhibits beta-lactamase enzymes produced by bacteria, enhancing Cefuroxime's activity and reducing resistance.
Can Raxclav 625 mg Tablet be used to treat viral infections?
No, Raxclav 625 mg Tablet is indicated only for bacterial infections. It does not treat viral infections such as common cold or flu.
What are the contraindications associated with the use of Raxclav 625 mg Tablet?
Raxclav 625 mg Tablet should be avoided by patients with known allergy to any of its ingredients. Inform your doctor about your medical history before taking this medicine to avoid any side effects.
Can the use of Raxclav 625 mg Tablet cause diarrhea?
Yes, the use of Raxclav 625 mg Tablet can cause diarrhea. Antibiotics can kill beneficial bacteria in the stomach and contribute to diarrhea. If you experience diarrhea, drink plenty of fluids. If it persists, talk to your doctor. Do not take other medications without consulting a medical professional.
Can I stop taking Raxclav 625 mg Tablet when I feel better?
No, do not stop taking Raxclav 625 mg Tablet and complete the full course of treatment even if you feel better. Your symptoms may improve before the infection is completely cured.
What are the instructions for the storage and disposal of Raxclav 625 mg Tablet?
Store Raxclav 625 mg Tablet in its original packaging, tightly closed. Follow the storage instructions on the label or package. Do not use if expired. If unused medicine is left over, dispose of it safely according to local guidelines to prevent accidental consumption by children, pets, and other people.
Take this medicine in the dose and duration as advised by your doctor. Swallow it whole without chewing, crushing, or breaking it. It may be taken with or without food, but it is better to take it at a fixed time.
- You have been prescribed this combination medicine to treat bacterial infections.
- Do not skip any doses and finish the full course of treatment even if you feel better.
- Take it with food to avoid an upset stomach.
- Diarrhea may occur as a side effect. Taking probiotics may help. Talk to your doctor if you notice bloody stools or develop abdominal cramps.
- Stop taking Raxclav 625 mg Tablet and inform your doctor immediately if you develop an itchy rash, swelling of the face, throat, or tongue, or breathing difficulties.
Alcohol
Consuming alcohol with Raxclav 625 mg Tablet does not cause any harmful side effects.
Breastfeed
Raxclav 625 mg Tablet is safe to use during breastfeeding. Human studies suggest that the drug does not pass into breastmilk in significant amounts and is not harmful to the baby.
Pregnancy
Raxclav 625 mg Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
